Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» J&J's Xarelto pads artery disease case by reducing amputation, death rates vs. aspirin
J&J's Xarelto pads artery disease case by reducing amputation, death rates vs. aspirin
J&J's Xarelto pads artery disease case by reducing amputation, death rates vs. aspirin
Submitted by
admin
on November 16, 2017 - 9:41am
Source:
Fierce Pharma
News Tags:
JNJ
Xarelto
blood thinners
PAD
coronary artery disease
Headline:
J&J's Xarelto pads artery disease case by reducing amputation, death rates vs. aspirin
Do Not Allow Advertisers to Use My Personal information
